WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Ownership - Who owns Athira Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Athira Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Perceptive Advisors LLCDirector2025-12-23329,756$6.35
$2.09MBuy
Perceptive Advisors LLCDirector2025-12-23989,270$6.35
$6.28MBuy
Mark James LittonPresident and CEO2025-07-0125,123$0.29
$7.36kSell
Mark WorthingtonGeneral Counsel and CCO2025-07-018,526$0.29
$2.50kSell
Robert RenningerSVP Finance and Accounting2025-07-012,897$0.29
$848.82Sell
Martin Javier SanCHIEF MEDICAL OFFICER2025-07-0110,842$0.29
$3.18kSell
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-07-018,526$0.29
$2.50kSell
Robert RenningerSVP Finance and Accounting2025-05-1910,000$0.23
$2.31kBuy
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-05-1910,000$0.23
$2.31kBuy
Robert RenningerVP of Finance2025-01-022,881$0.56
$1.62kSell

1 of 2

ATHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATHA insiders and whales buy or sell their stock.

ATHA Shareholders

What type of owners hold Athira Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC145.36%5,732,720$42.42MInsider
Joseph Edelman78.98%3,114,805$23.05MInsider
Rtw Investments LP67.67%2,668,913$19.75MInsider
Perceptive Advisors LLC13.70%540,296$4.00MInstitution
Mark James Litton8.76%345,491$2.56MInsider
Bml Capital Management LLC8.19%323,066$2.39MInstitution
Kevin Church4.28%168,901$1.25MInsider
Glenna Mileson4.06%159,930$1.18MInsider
John M. Fluke Jr.3.94%155,346$1.15MInsider
Vanguard Group Inc3.90%153,789$1.14MInstitution

1 of 3

ATHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHA11.69%88.31%Net BuyingNet Buying
PLUR0.04%99.96%Net Buying
EVAX0.42%0.00%
BRNS22.46%53.40%
HYPD3.61%96.39%Net BuyingNet Buying
View Top Biotech Stocks

Athira Pharma Stock Ownership FAQ

Who owns Athira Pharma?

Athira Pharma (NASDAQ: ATHA) is owned by 43.52% institutional shareholders, 328.62% Athira Pharma insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Athira Pharma shareholder, owning 5.73M shares representing 145.36% of the company. Perceptive Advisors LLC's Athira Pharma shares are currently valued at $43.05M.

If you're new to stock investing, here's how to buy Athira Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.